ロード中...
Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer’s disease
Several potential disease-modifying drugs for Alzheimer’s disease (AD) have failed to show any effect on disease progression in clinical trials, conceivably because the AD subjects are already too advanced to derive clinical benefit from treatment and because diagnosis based on clinical criteria alo...
保存先:
| 出版年: | Alzheimers Dement |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4386839/ https://ncbi.nlm.nih.gov/pubmed/24795085 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2014.02.004 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|